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The course of a series of kidney diseases is characterized by impaired immunity 
additionally altered during haemodialysis and after renal transplantation. The study cov­
ered 50 patients divided into three groups: 16 patients with chronic renal failure (CRF), 23 
ones on periodic haemodialysis (PHD), and 11 after renal transplantation. Flowcytometric 
immunophenotyping by means of FACS-analysis using monoclonal antibodies was carried 
out. The investigation aimed at revealing the changes in the cell immunity, activation of 
surface markers and adhesion molecules in these patients. Statistically significant changes 
in the expression of 1С AM-1 adhesion molecules were established as followed: CD54+/ 
CD4+ = 24,8 ± 11,6 (in CRF) against 14,9 ± 8,1 (in PHD) atp < 0,05 and CD54+/CD8+ 
= 17 ± 6,9 (in CRF) against 10,3 ± 4,8 (in PHD) at p < 0,05. A conclusion was drawn that 
immune response damage in PHD patients resulted mainly from the lowered expression of 
the adhesion molecules of the ICAM-1 immunoglobulin gene superfamily. 
Key-words: Chron ic renal fa i lure , haemodia lys is , f low cytometry, 
immunophenotyping, I C A M - 1 adhesion molecules 
There exists a serious distur­
bance in the reactivity of the patients 
with chronic renal failure ( C R F ) and on 
periodic haemodialysis (PHD) that is 
explained by their reduced resistance 
towards infection (2). Recently, Japa­
nese investigators (4) reported a con-
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siderable damage of gamma-delta T -
cells in patients on P H D but a less ex­
pressed one - in C A P D as compared 
with healthy controls. In these authors' 
opinion, the aforementioned cells were 
susceptible to activation-induced cell 
death (apoptosis). It was supposed that 
cell immunity could be influenced in 
P H D patients depending on the kind of 
dialyzer membrane and its biological 
compatibility. 
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It is well known that there are 
lesions of the lymphocytic and polymor­
phonuclear leukocytic functions in pa­
tients on PHD. The process of extra­
corporeal circulation itself is accompa­
nied by a periodic contact of blood with 
various artificial non-physiological 
materials such as dialyzer membranes, 
haemolines, puncture needles, cath­
eters, etc. Depending on the composi­
tion of these materials and consumer 
means a change in the activity of mono­
nuclear cells occurs resulting in a chain 
act ivat ion of whole cascades of 
cytokines, interleukins and other bio­
logically active mediators as well (3). 
The purpose of the present in­
vestigation is to compare the changes 
in the cell-mediated immunity in pa­
tients with C R F on P H D and after re­
nal transplantation by means of study­
ing the lymphocytic populations and 
subpopulations, some activation mark­
ers and adhesion molecules as well . 
MATERIAL AND METHODS 
The trial covered 50 patients (36 
males and 14 females) aged between 25 
and 60 years and hospitalized in the 
C l i n i c of Nephrology and 
Haemodialysis, Department of Neph­
rology, Haemodia lys i s and 
Haematology, Medical University of 
Varna. They were divided into three 
main groups: 1)16 patients with C R F ; 
2) 23 patients on P H D with duration of 
dialysis treatment between one month 
and 12 years. A l l the P H D patients un­
derwent 12-hour long haemodialysis 
procedures threefold weekly and were 
regularly given erythropoietin. Cellu­
lose-acetate and polysulphonic dialyzer 
membranes were used, and 3) 11 pa­
tients (9 males and 2 females) aged be­
tween 40 and 60 years after renal trans­
plantation predominantly from live do­
nors. A l l the transplanted patients were 
administered cort icosteroids and 
imuran but 8 of them only - addition­
ally cyclosporin A . Immunophen-
otyping was performed according to the 
following protocol: 
Samples: whole blood taken by 
venipuncture into K 3 heparin 
VACUTAINER®. Preparation of lym­
phocytes ( L y ) : standard procedure for 
two-colour direct immunofluorescence 
of Ly subsets in erythrocyte-lysed whole 
blood; washing (Washing solution), lys-
ing (Lysing solution), and fixing with 
1,5 % paraformaldehyde ( C e l l F i x ) . 
Monoclonal antibodies ( M C A ) : combi­
nation of M C A conjugated with fluo­
rescein isothiocyanate ( F I T C ) or phy-
coerythrin ( P E ) . 
1) C e l l immunity - Becton 
Dickinson ( B D ) Simultest I M K P l u s 
reagent kit was used as followed: C D 3 / 
C D 19 - total T Ly (CD3+) and total В 
L y ( C D 19+); CD4/CD18 - T helper/in-
ducer (CD4+) and T suppressor/cyto-
toxic (CD8) ; CD3/CD16+56+ - N K -
natural killer (CD3-/CD16+56+). 
2) Activated T L y : a) early acti­
vated T h and Ts - by expression of 
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nterleukin-2R ( I L - 2 R ) (CD25): CD25/ 
CD4 - activated Th L y ; CD25/CD8 -
activated Ts L y ; b) late activated total 
T Ly - by expression of C D 3 / H L A - D R . 
3) Adhesion molecules: I C A M -
1 (CD54), L F A - 1 (CD1 la) and M A C -
1 ( C D l i b ) - by expression on T L y : 
C D 5 4 / C D 4 - expression on T h and 
C D 5 4 / C D 8 - for expression on Ts ; 
C D l l a / C D 8 - expression on Ts and 
CD1 lb/CD8 - for expression on Ts. 
For the cytometric analysis of 
Ly subsets, a FACSort flowcytometer 
(Becton Dickinson) was used, isotope 
control was done with LeucoGATE and 
Simulset I M K plus software was ap­
plied for data evaluation. A statistical 
data processing was performed after the 
method of Student-Fisher. 
RESULTS AND DISCUSSION 
As shown on Fig. 1, the changes 
of CD3 parameter consisted in an in­
significant increase of total T L y in the 
patients on PHD as compared to these 
with C R F but in a statistically signifi­
cant increase of these lymphocytes in 
the transplanted patients (p < 0,05). The 
late activated total T L y ( C D 3 / H L A -
D R ) were considerably higher in the 
transplanted patients (Fig. 2). During 
the T Ly activation a cascade of intrac­
ellular biochemical processes was ini­
tiated accompanied by typical morpho­
logical alterations in blast transforma­
tion. It was obvious (Fig. 3) that В L y 
( C D 19) gradually reduced in the three 
patients' groups. This parameter was 
x ± S D p<0,05: 
P H D 
Fig. 1. CD3 in patients with CRF, on PHD, 
and after RT 




Fig. 2. Activated T-ly in patients with CRF, 
on PHD, and after RT 
statistically significantly diminished in 
the patients after renal transplantation 
which testified to the effective immu­
nosuppressive therapy. These results 
cound be also interpreted as a manifes­
tation of the acute modulation of the 
phagocytic function by the extracorpo­
real circulation in the patients on P H D . 
Antibody deficiency is, in general, char­
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The CD4/CD3 ratio (Fig. 4) re-
X ± S D p<o,05: ****** fleets the processes of T-cell activation. 
It is considered as lowered when it is 
below 1,5 (3). The kidney transplanta­
tion statistically significantly reduces 
the C D 4 / C D 8 ratio when compared 
with PHD alone. It has been established 
that when the CD4/CD8 index in the 
peripheral blood is higher then the 
perivascular ratio is higher, too, and thus 
the rejecting reaction is reversible (1). 
It is known that I C A M - 1 medi­
ate the adhesion of Т-cells with anti­
gen-presenting cells towards the acti­
vated endothelium. I C A M - 1 play the 
role of co-stimulating signals for T - L y 
activation and realize the interactions 
between T - and B - L y and the penetra­
tion of T - L y into the extravasal space 
thus enabling the transendothelial mi­
gration (3). In our material, there were 
statistically significant differences in the 
expression of I C A M - 1 adhesion mol­
ecules (Table 1). In the patients on PHD, 
the expression of the adhesion mol­
ecules on Т-helper and T-suppressor 
Fig. 4. CD4/CD8 inpatients with CRF on PHD, c e l l s i s l o w e r t h a n t h a t i n t h e P a t i e n t s 
and after RT with C R F : CD54+/CD4+ = 24,8 ± 11,6 
(in C R F ) against 14,9 ± 8,1 (in P H D ) 
at p < 0,05 and CD54+/CD8+ = 17 ± 
Table 1 
Expression of adhesion molecules on lymphocytes 
MCA CD54+CD3- CD54+CD3+ CD54+CD4- CD54+CD4+ CD54+CD8+ CD54+CD8-
PHD 14,8 20,5 33,6 14,9 33,4 10,3 
SD 4 12,5 6,6 8,1 9,6 4,8 
C R F 20,4 32,1 44,8 24,8 50,8 17 
SD 5,7 17,8 9,4 11,6 13,7 6,9 
P< 0,07 0,1 0,06 0,05 0,05 0,05 
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Fig. 3. CD 19 in patients with CRF, on PHD, 
and after RT 
x ± S D p<0,05:*,* 
PHD** 
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,9 (in C R F ) against 10,3 ± 4,8 (in 
P H D ) at p < 0,05. 
CONCLUSION 
The changes in the lymphocytic 
populations and subpopulations such as 
C D 3 , C D 3 / H L A - D R , C D 19, and CD4/ 
CD8 as well as the decreased expres­
sion of the adhesion molecules of the 
I C A M - 1 immunoglobulin gene super-
family in C R F patients as compared 
with that in the patients on P H D and 
after renal transplantation could be due 
to the disturbed immunologic homeo­
stasis caused by several factors of the 
renal pathology typical of these patients 
such as infections, etiology of the basic 
disease, duration of P H D treatment, 
composition of the dialyzer membrane, 
kind of dialysis solution, erythropoietin 
treatment, etc. The action of these fac­
tors results in the decreased liberation 
of 1L-2 and other mediators of inflam­
mation such as leukotriens, TNF-alpha, 
I L - 1 , etc. (5). That is why each param­
eter should be individually interpreted 
taking into consideration the involve­
ment of additional factors with the 
single patient. 
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Ф л о у ц и т о м е т р и ч н и п р о у ч в а н и я на к л е т ъ ч н и я и м у н и т е т 
при болни с у р е м и я , на периодична хемодиализа 
и след б ъ б р е ч н а т р а н с п л а н т а ц и я 
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Резюме: Редица бъбречни заболявания протичат с увреден имунитет, който 
допълнително се променя при хемодиализа в зависимост от вида на прилаганите 
мембрани. Изследвани са 50 болни, разпределени в 3 групи: 16 - с хронична бъбречна 
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недостатъчност (CRF) . 23 - на периодична хемодиализа (PHD) и 11 - след бъбречна 
трансплантация. Проведено е флоуцитометрично имунофеногипизиране чрез FACS-
анализа с използване на моноклонални антитела. Целта на изследването е установяване 
на промените в клетъчния имунитет, както и на активирането на повърхностните 
маркери и адхезионните молекули у болните. Намерени са статистически значими 
промени в експресията на адхезионните молекули ICAM-1: CD54+/CD4+ = 25 ± 10,2 
(при CRF) срещу 15 ± 7,1 (при PHD) (р < 0,05) и CD54+/CD8+ = 17 ±6 ,6 (при CRF) 
срещу 10 ± 4,5 (при PHD) (р < 0,05). Авторите заключават, че увреждането на имунния 
отговор се увеличава у диализно болните главно в резултат на снижената експресия 
на адхезионните молекули на имуноглобулиновата генна суперфамилия ICAM-1. 
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